也为我们的研究提供了参考。大部分COVID-19患者的影像学特点是显著

It also provides a reference for our research. <br>The imaging characteristics of most patients with COVID-19 are significant. It helps clinicians to better identify similar diseases and can be used as a supporting evidence for diagnosis. Like patient1 in our report, with chronic pulmonary fibrosis, if there is a lack of imaging, some symptoms such as cough and chest tightness will be mistaken for the manifestation of the original underlying disease. Dahai Zhao and other studies also pointed out that "[6], when there are other lung infections, the symptoms may not be distinguishable; and the blood test changes are more significant lymphocytes and CRP, but they will also change accordingly during other infections Imaging can be used as an important tool in the differential diagnosis of suspected patients. <br>At present, there are no drugs that specifically treat COVID-19, and the timing of hormone therapy is still controversial. Given its mechanism of action, clinical symptoms may be masked. The effect on the body's immunity will also affect the positive rate of nucleic acids, but the imaging performance is relatively delayed by its influence, which can be used as a reference for the disease and the body's virus clearance during the treatment process. Scholars encourage standardization in the context of global medical resources And explore effective methods of auxiliary diagnosis and treatment [7], for patients with partial reversion to yang after reversion, with the development of detection methods and further understanding of new coronary pneumonia, there will be a deeper understanding, but at this stage, imaging is a disease Important factors for assessment, existing studies indicate

It also provides a reference for our research.<br>The imaging characteristics of most COVID-19 patients are significant and help clinicians better identify similar diseases, which can be used as evidence of diagnosis. As we reported in patient1, combined with chronic pulmonary fibrosis, if the lack of imaging, some symptoms such as coughing, chest tightness can be mistaken for the original symptoms of the underlying disease. Dahai Zhao and other studies also point out that "symptoms may not be identifiable when other lung infections occur, while blood tests are significantly different from lymphocytes and CRP, but they can also change in other infections, so imaging can be used as an important tool in the differential diagnosis of suspected patients."<br>There is currently no specific treatment of COVID-19 drugs, the timing of the use of hormone therapy is still controversial, in view of its mechanism of action, may make clinical symptoms covered up, its role in the body's immunity will also affect the positive rate of nucleic acids, but the imaging performance by its effects are relatively lagging, can be used as a reference for the treatment process of the disease and the body virus removal situation. Scholars encourage the regulation and search for effective auxiliary diagnosis and treatment in the context of global medical resources, for some patients after re-yang, with the development of testing methods and for the new coronary pneumonia to learn more about the further understanding, but at this stage, imaging is an important factor in the assessment of the disease, the current study pointed out that

It also provides a reference for our research.<br>The imaging features of most patients with covid-19 are significant. It is helpful for clinicians to better identify similar diseases and can be used as a favorable evidence for diagnosis. For example, patient1 in our report, combined with chronic pulmonary fibrosis, if there is no image, some symptoms such as cough and chest distress will be mistaken as the performance of the original basic diseases. Dahai Zhao and other researches also pointed out that "[6], when there are other lung infections, the symptoms may not be differentiated; the blood examination changes are more significant in lymphocytes and CRP, but they will also change in other infections, so the image can be an important tool for the differential diagnosis of suspected patients.<br>At present, there is no specific drug to treat covid-19, and the timing of hormone therapy is still controversial. In view of its mechanism of action, the clinical symptoms may be covered up, and its effect on the immune system may also affect the positive rate of nucleic acid, but the imaging performance is relatively delayed by its influence, which can be used as a reference for the treatment of disease and virus clearance. Scholars have encouraged the novel coronavirus pneumonia to be standardized and explored for effective diagnosis and treatment under the condition of global medical resources shortage. [7], for some patients who have been negative for relapse, will have a better understanding with the development of detection methods and further understanding of new crown pneumonia. But at this stage, imaging is an important factor in disease assessment.